Feb. 13, 2022
compound 15
NaPi2b inhibitor preclinical (hyperphosphatemia) in-house compound screen + optimization J. Med. Chem. Kyowa Kirin Co., Ltd.
NaPi2b inhibitor preclinical (hyperphosphatemia) in-house compound screen + optimization J. Med. Chem. Kyowa Kirin Co., Ltd.